Multi-dimensional analysis reveals the potential of PDK4 as a tumor biomarker and target for immunotherapy
PDK4 is a promising pan-cancer diagnostic/prognostic biomarker and potential immunotherapy target, providing a basis for personalized cancer treatment.
Authors
- Chenglin Wang (ORCID: https://orcid.org/0000-0002-1744-886X)
- Yaxing Deng
- Xin Wang
Institutions
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1007/s12672-026-04656-3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00